Biotech startup funding in 2024
Every new Form D round of US startups in Biotech & Pharma first filed in 2024.
468 biotech startups filed a new Form D round in 2024. Together they reported $10.96B sold in 515 rounds. The median round was $5.0M.
Companies
468
with a new round in 2024
Reported sold
$10.96B
515 rounds
Median round
$5.0M
rounds with an amount
Largest round
$421.7M
Treeline Biosciences, Inc.
New funding by month
Amount reported sold in new Form D rounds, by the month each round was first filed. Hover a bar for the number of rounds.
Show as table
| Month | Rounds | Reported sold |
|---|---|---|
| December 2024 | 51 | $565.0M |
| November 2024 | 37 | $720.1M |
| October 2024 | 49 | $1.22B |
| September 2024 | 33 | $1.01B |
| August 2024 | 41 | $837.0M |
| July 2024 | 45 | $1.33B |
| June 2024 | 40 | $439.1M |
| May 2024 | 54 | $1.15B |
| April 2024 | 41 | $1.05B |
| March 2024 | 44 | $1.13B |
| February 2024 | 34 | $741.7M |
| January 2024 | 46 | $741.7M |
July 2024 was the largest month, at $1.33B in 45 rounds.
Biotech companies that raised the most in 2024
| # | Company | Reported sold | Rounds | Focus | Latest round |
|---|---|---|---|---|---|
| 1 | Treeline Biosciences, Inc.Watertown, MA | $421.7M | 1 | Therapeutics | Oct 17, 2024 |
| 2 | Mirador Therapeutics, Inc.San Diego, CA | $412.9M | 2 | Therapeutics | Apr 3, 2024 |
| 3 | TrialSpark, Inc.New York, NY | $372.2M | 1 | Therapeutics | Jul 2, 2024 |
| 4 | Arsenal Biosciences, Inc.South San Francisco, CA | $325.3M | 1 | Cell and gene therapy | Sep 4, 2024 |
| 5 | Cardurion Pharmaceuticals, Inc.Burlington, MA | $260.4M | 1 | Therapeutics | Jul 24, 2024 |
| 6 | Capstan Therapeutics, Inc.San Diego, CA | $226.9M | 3 | Cell and gene therapy | Mar 20, 2024 |
| 7 | Seaport Therapeutics, Inc.Boston, MA | $225.8M | 1 | Therapeutics | Oct 31, 2024 |
| 8 | Metsera, Inc.New York, NY | $214.9M | 1 | Therapeutics | Nov 20, 2024 |
| 9 | Candid Therapeutics, Inc.San Diego, CA | $206.2M | 1 | Therapeutics | Sep 13, 2024 |
| 10 | Zenas BioPharma, Inc.Waltham, MA | $200.1M | 1 | Therapeutics | May 14, 2024 |
| 11 | TheRas, Inc.Palo Alto, CA | $200.0M | 1 | Therapeutics | May 15, 2024 |
| 12 | BioAge Labs, Inc.Richmond, CA | $194.3M | 1 | Therapeutics | Feb 13, 2024 |
| 13 | Aktis Oncology, Inc.Boston, MA | $175.0M | 1 | Therapeutics | Oct 2, 2024 |
| 14 | Endo, Inc.Malvern, PA | $170.5M | 1 | Therapeutics | Mar 21, 2024 |
| 15 | TORL Biotherapeutics LLCCulver City, CA | $158.3M | 1 | Therapeutics | Apr 17, 2024 |
| 16 | Cellanome, Inc.Foster City, CA | $149.9M | 1 | Life science tools and services | Jan 29, 2024 |
| 17 | Syncromune, Inc.Fort Lauderdale, FL | $144.8M | 1 | Therapeutics | Dec 17, 2024 |
| 18 | NGM Bio Holdings, Inc.South San Francisco, CA | $142.0M | 1 | Therapeutics | Jul 17, 2024 |
| 19 | Endeavor Biomedicines, Inc.San Diego, CA | $132.5M | 1 | Therapeutics | May 3, 2024 |
| 20 | Rivus Pharmaceuticals, Inc.Charlottesville, VA | $131.9M | 2 | Therapeutics | Sep 17, 2024 |
| 21 | Alumis Inc.South San Francisco, CA | $129.4M | 1 | Therapeutics | Mar 11, 2024 |
| 22 | Alzheon, Inc.Framingham, MA | $126.2M | 1 | Therapeutics | Mar 12, 2024 |
| 23 | Scorpion Therapeutics, Inc.Boston, MA | $125.6M | 1 | Therapeutics | Jul 16, 2024 |
| 24 | Neurona Therapeutics, Inc.South San Francisco, CA | $119.9M | 1 | Cell and gene therapy | Feb 13, 2024 |
| 25 | Reunion Neuroscience, Inc.Morristown, NJ | $119.8M | 1 | Therapeutics | Jan 25, 2024 |
Largest rounds of 2024
All industries →| Company | Focus | Location | Amount sold | Investors | Filing |
|---|---|---|---|---|---|
Treeline Biosciences, Inc.Repeat raise · October 17, 2024 | Therapeutics | Watertown, MA | $421.7M | 43 | Form D ↗ |
TrialSpark, Inc.First Form D · July 2, 2024 | Therapeutics | New York, NY | $372.2M | 16 | Form D ↗ |
Mirador Therapeutics, Inc.Repeat raise · April 3, 2024 | Therapeutics | San Diego, CA | $332.9M | 31 | Form D ↗ |
Arsenal Biosciences, Inc.Repeat raise · September 4, 2024 | Cell and gene therapy | South San Francisco, CA | $325.3M | 26 | Form D ↗ |
Cardurion Pharmaceuticals, Inc.Repeat raise · July 24, 2024 | Therapeutics | Burlington, MA | $260.4M | 19 | Form D ↗ |
Seaport Therapeutics, Inc.First Form D · October 31, 2024 | Therapeutics | Boston, MA | $225.8M | 33 | Form D ↗ |
Metsera, Inc.First Form D · November 20, 2024 | Therapeutics | New York, NY | $214.9M | 38 | Form D ↗ |
Candid Therapeutics, Inc.First Form D · September 13, 2024 | Therapeutics | San Diego, CA | $206.2M | 33 | Form D ↗ |
Zenas BioPharma, Inc.Repeat raise · May 14, 2024 | Therapeutics | Waltham, MA | $200.1M | 26 | Form D ↗ |
TheRas, Inc.First Form D · May 15, 2024 | Therapeutics | Palo Alto, CA | $200.0M | 15 | Form D ↗ |
Where these companies are
Every Biotech & Pharma round of 2024 515
All industries →How this page is built
- Which rounds. New Form D offerings of US startups in Biotech & Pharma first filed in 2024, dated by that first filing. Later amendments update an amount; they are not new rounds.
- Ranking. By the total reported sold across a company's rounds of 2024. Two SEC filers of one company, such as a holding company and its operating company, count as one company, under the name on the newest filing.
- Left out. Public companies, companies based outside the US, and mergers or spin-offs. Some companies raise money without filing a Form D.